1. Home
  2. BCAB vs ELBM Comparison

BCAB vs ELBM Comparison

Compare BCAB & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ELBM
  • Stock Information
  • Founded
  • BCAB 2007
  • ELBM 2011
  • Country
  • BCAB United States
  • ELBM Canada
  • Employees
  • BCAB N/A
  • ELBM N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ELBM Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • ELBM Miscellaneous
  • Exchange
  • BCAB Nasdaq
  • ELBM Nasdaq
  • Market Cap
  • BCAB 22.3M
  • ELBM 18.5M
  • IPO Year
  • BCAB 2020
  • ELBM N/A
  • Fundamental
  • Price
  • BCAB $0.38
  • ELBM $1.06
  • Analyst Decision
  • BCAB Buy
  • ELBM Strong Buy
  • Analyst Count
  • BCAB 2
  • ELBM 1
  • Target Price
  • BCAB $1.00
  • ELBM $2.20
  • AVG Volume (30 Days)
  • BCAB 507.7K
  • ELBM 714.9K
  • Earning Date
  • BCAB 08-07-2025
  • ELBM 08-13-2025
  • Dividend Yield
  • BCAB N/A
  • ELBM N/A
  • EPS Growth
  • BCAB N/A
  • ELBM N/A
  • EPS
  • BCAB N/A
  • ELBM N/A
  • Revenue
  • BCAB $11,000,000.00
  • ELBM N/A
  • Revenue This Year
  • BCAB N/A
  • ELBM N/A
  • Revenue Next Year
  • BCAB N/A
  • ELBM N/A
  • P/E Ratio
  • BCAB N/A
  • ELBM N/A
  • Revenue Growth
  • BCAB N/A
  • ELBM N/A
  • 52 Week Low
  • BCAB $0.24
  • ELBM $0.91
  • 52 Week High
  • BCAB $2.53
  • ELBM $2.83
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 42.24
  • ELBM 51.17
  • Support Level
  • BCAB $0.36
  • ELBM $1.05
  • Resistance Level
  • BCAB $0.43
  • ELBM $1.14
  • Average True Range (ATR)
  • BCAB 0.04
  • ELBM 0.05
  • MACD
  • BCAB -0.00
  • ELBM 0.00
  • Stochastic Oscillator
  • BCAB 16.00
  • ELBM 46.15

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

Share on Social Networks: